Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06621329 · ClinicalTrials.gov registry record · Phase 2
Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache
A Phase 2 study of Headache and SAH (Subarachnoid Hemorrhage), sponsored by University of California, Davis.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06621329: Recruiting Phase 2 study of Headache and SAH (Subarachnoid Hemorrhage), sponsored by University of California, Davis.
NCT06621329 is a Phase 2 study of Headache and SAH (Subarachnoid Hemorrhage) that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 40 participants, below the 154-participant average among 35 other Headache trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06621329, a Phase 2 study of Headache and SAH (Subarachnoid Hemorrhage), is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The study titled \"Transnasal sphenopalatine ganglion block for treatment of acute subarachnoid hemorrhage associated headache\" is a randomized controlled pilot study aimed at evaluating the efficacy of a transnasal sphenopalatine ganglion (SPG) block in addition to standard pain medication for reducing headache severity in patients with acute subarachnoid hemorrhage (aSAH). The study also examines whether this intervention can reduce opioid requirements during hospitalization and upon discharge.
Primary Outcome
Pain scores will be obtained at regular intervals to compare pain control between the two arms. Pain scores will be collected multiple times throughout each ICU day, up to ICU day 14.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Transnasal sphenopalatine ganglion block
Study Locations (1)
California
- UC Davis Medical Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-10-17 |
| Est. Completion | 2026-10 |
| Phase | Phase 2 |
What NCT06621329 shows while recruiting
NCT06621329 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 154-participant average among 35 other Headache trials with a reported enrollment target (74% lower).
The record links to 2 conditions, with Headache appearing as the primary indexed condition, and to 1 intervention - of which Transnasal sphenopalatine ganglion block is the first listed.
NCT06621329 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06621329 about?
NCT06621329 is a clinical study titled "Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache". The study titled \"Transnasal sphenopalatine ganglion block for treatment of acute subarachnoid hemorrhage associated headache\" is a randomized controlled pilot study aimed at evaluating the efficacy of a transnasal sphenopalatine ganglion (SPG) block in addition to standard pain medication...
What is the current status of trial NCT06621329?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2024-10-17. Estimated completion is 2026-10.
What conditions does trial NCT06621329 study?
This clinical trial studies the following conditions: Headache, SAH (Subarachnoid Hemorrhage).
What interventions are being tested in trial NCT06621329?
The interventions under investigation include: Transnasal sphenopalatine ganglion block (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT06621329?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06621329 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Headache
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06621329's enrollment target sits among peer trials
40 24th of 35 higher than 11 of 35 other Headache trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Headache trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
RECRUITING · Phase 2
-
Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage
RECRUITING · Phase 2
-
BLOCK-SAH - PPF-Block for Post-SAH Headache
RECRUITING · Phase 2
-
Concussion Recovery and Support Program
RECRUITING · NA
-
Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches
RECRUITING
-
Puberty, Testosterone, and Brain Development
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI